Suppr超能文献

《国家共病调查复制版青少年补充调查》中12个月内DSM-IV疾病的严重程度。

Severity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement.

作者信息

Kessler Ronald C, Avenevoli Shelli, Costello Jane, Green Jennifer Greif, Gruber Michael J, McLaughlin Katie A, Petukhova Maria, Sampson Nancy A, Zaslavsky Alan M, Merikangas Kathleen Ries

机构信息

Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Arch Gen Psychiatry. 2012 Apr;69(4):381-9. doi: 10.1001/archgenpsychiatry.2011.1603.

Abstract

CONTEXT

Estimates of DSM-IV disorder prevalence are high; stringent criteria to define need for services are desired.

OBJECTIVE

To present US national data on the prevalence and sociodemographic correlates of 12-month serious emotional disturbance (SED), defined by the US Substance Abuse and Mental Health Services Administration, from the National Comorbidity Survey Replication Adolescent Supplement.

DESIGN

The National Comorbidity Survey Replication Adolescent Supplement is a national survey of DSM-IV anxiety, mood, behavior, and substance disorders among US adolescents.

SETTING

Dual-frame household and school samples of US adolescents.

PARTICIPANTS

Total of 6483 pairs of adolescents aged 13 to 17 (interviews) and parents (questionnaires).

MAIN OUTCOME MEASURES

The DSM-IV disorders were assessed with the World Health Organization Composite International Diagnostic Interview and validated with blinded clinical interviews based on the Schedule for Affective Disorders and Schizophrenia for School-Age Children. Serious emotional disturbance was operationalized as a DSM-IV/Composite International Diagnostic Interview disorder with a score of 50 or less on the Children's Global Assessment Scale (ie, moderate impairment in most areas of functioning or severe impairment in at least 1 area). Concordance of Composite International Diagnostic Interview SED diagnoses with blinded Schedule for Affective Disorders and Schizophrenia for School-Age Children diagnoses was good.

RESULTS

The estimated prevalence of SED was 8.0%. Most SEDs were due to behavior (54.5%) or mood (31.4%) disorders. Although respondents with 3 or more disorders made up only 29.0% of those with 12-month DSM-IV/Composite International Diagnostic Interview disorders, they constituted 63.5% of SEDs. Predictive effects of high comorbidity were significantly greater than the product of their disorder-specific odds ratios and consistent across disorder types. Associations of sociodemographic variables with SED were generally nonsignificant after controlling for disorder type and number.

CONCLUSIONS

The high estimated 12-month prevalence of DSM-IV disorders among US adolescents is largely due to mild cases. The significant between-disorder differences in risk of SED and the significant effect of high comorbidity have important public health implications for targeting interventions.

摘要

背景

《精神疾病诊断与统计手册》第四版(DSM-IV)中对精神障碍患病率的估计值较高;因此需要严格的标准来界定服务需求。

目的

通过《国家共病调查复制版青少年补充调查》,呈现美国国家药物滥用和精神健康服务管理局所定义的12个月严重情绪障碍(SED)的患病率及社会人口学相关因素的数据。

设计

《国家共病调查复制版青少年补充调查》是一项针对美国青少年的DSM-IV焦虑、情绪、行为和物质使用障碍的全国性调查。

地点

美国青少年的双框架家庭和学校样本。

参与者

共有6483对年龄在13至17岁的青少年(访谈)及其父母(问卷调查)。

主要观察指标

采用世界卫生组织综合国际诊断访谈评估DSM-IV障碍,并根据学龄儿童情感障碍和精神分裂症量表通过盲法临床访谈进行验证。严重情绪障碍被定义为DSM-IV/综合国际诊断访谈障碍,且儿童总体评估量表得分在50分及以下(即大多数功能领域存在中度损害或至少一个领域存在严重损害)。综合国际诊断访谈中SED诊断与盲法学龄儿童情感障碍和精神分裂症量表诊断的一致性良好。

结果

SED的估计患病率为8.0%。大多数SED是由行为障碍(54.5%)或情绪障碍(31.4%)引起的。虽然患有3种或更多障碍的受访者仅占12个月内患有DSM-IV/综合国际诊断访谈障碍者的29.0%,但他们却占SED患者的63.5%。高共病的预测效应显著大于其特定障碍比值比的乘积,且在不同障碍类型中一致。在控制了障碍类型和数量后,社会人口学变量与SED的关联通常不显著。

结论

美国青少年中DSM-IV障碍12个月患病率估计值较高主要归因于轻症病例。SED风险在不同障碍之间存在显著差异,且高共病具有显著影响,这对干预措施的针对性具有重要的公共卫生意义。

相似文献

1
Severity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement.
Arch Gen Psychiatry. 2012 Apr;69(4):381-9. doi: 10.1001/archgenpsychiatry.2011.1603.
2
Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement.
Arch Gen Psychiatry. 2012 Apr;69(4):372-80. doi: 10.1001/archgenpsychiatry.2011.160. Epub 2011 Dec 5.
3
5
Intermittent explosive disorder in the National Comorbidity Survey Replication Adolescent Supplement.
Arch Gen Psychiatry. 2012 Nov;69(11):1131-9. doi: 10.1001/archgenpsychiatry.2012.592.
9
National comorbidity survey replication adolescent supplement (NCS-A): III. Concordance of DSM-IV/CIDI diagnoses with clinical reassessments.
J Am Acad Child Adolesc Psychiatry. 2009 Apr;48(4):386-399. doi: 10.1097/CHI.0b013e31819a1cbc.

引用本文的文献

1
MRI markers of neuroinflammation in untreated patients with subclinical generalized anxiety disorder.
J Neural Transm (Vienna). 2025 Sep 11. doi: 10.1007/s00702-025-03014-x.
3
Psychosocial outcomes after adolescent metabolic and bariatric surgery: a narrative review of the literature.
Surg Obes Relat Dis. 2025 Jan;21(1):16-23. doi: 10.1016/j.soard.2024.09.003. Epub 2024 Sep 14.
6
Opportunities of measuring hierarchical models of psychopathology.
JCPP Adv. 2023 Jul 22;3(4):e12187. doi: 10.1002/jcv2.12187. eCollection 2023 Dec.
7
Validating the Children's Depression Inventory-2: Results from the Growing Up in Singapore Towards Healthy Outcomes (GUSTO) study.
PLoS One. 2023 May 25;18(5):e0286197. doi: 10.1371/journal.pone.0286197. eCollection 2023.
8
The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder.
Expert Opin Pharmacother. 2023 May;24(7):835-847. doi: 10.1080/14656566.2023.2199921. Epub 2023 Apr 19.
9
Comprehensive Prevention: An Evaluation of Peripheral Outcomes of a School-based Prevention Program.
Res Child Adolesc Psychopathol. 2023 Jul;51(7):921-936. doi: 10.1007/s10802-023-01043-2. Epub 2023 Mar 4.

本文引用的文献

1
The Loss of Sadness: How Psychiatry Transformed Normal Sorrow Into Depressive Disorder.
Am J Psychiatry. 2007 Nov 1;164(11):1764-1765. doi: 10.1176/appi.ajp.2007.07081263.
2
Lifetime co-morbidity of DSM-IV disorders in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A).
Psychol Med. 2012 Sep;42(9):1997-2010. doi: 10.1017/S0033291712000025. Epub 2012 Jan 25.
3
Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement.
Arch Gen Psychiatry. 2012 Apr;69(4):372-80. doi: 10.1001/archgenpsychiatry.2011.160. Epub 2011 Dec 5.
4
Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A).
J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):980-9. doi: 10.1016/j.jaac.2010.05.017. Epub 2010 Jul 31.
5
Design and field procedures in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A).
Int J Methods Psychiatr Res. 2009 Jun;18(2):69-83. doi: 10.1002/mpr.279.
6
National comorbidity survey replication adolescent supplement (NCS-A): III. Concordance of DSM-IV/CIDI diagnoses with clinical reassessments.
J Am Acad Child Adolesc Psychiatry. 2009 Apr;48(4):386-399. doi: 10.1097/CHI.0b013e31819a1cbc.
7
National comorbidity survey replication adolescent supplement (NCS-A): I. Background and measures.
J Am Acad Child Adolesc Psychiatry. 2009 Apr;48(4):367-379. doi: 10.1097/CHI.0b013e31819996f1.
8
National comorbidity survey replication adolescent supplement (NCS-A): II. Overview and design.
J Am Acad Child Adolesc Psychiatry. 2009 Apr;48(4):380-385. doi: 10.1097/CHI.0b013e3181999705.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验